EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Associations between impaired awareness of hypoglycaemia and mental health in insulin‐treated type 2 and type 1 diabetes in the Hypo‐ METRICS study

Aisling McCarthy iD, Jonah Thomas iD, Eduardo Avila iD, Vaios Koutroukas, Beatrice Pieri, Natalie Zaremba iD, Stephanie A Amiel iD, François Pouwer iD, Pratik Choudhary iD, Patrick Divilly, Hypo‐RESOLVE Consortium

Diabetic Medicine · 2026-03 · 43 (3)

DOI: 10.1111/dme.70194 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetic Medicine, online erschienen am 23.01.2026. Verfasst von Aisling McCarthy und 10 weiteren Autor:innen. Beteiligte Einrichtung: University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Hypoglycemia, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Insulin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovative Medicines Initiative 2 Joint Undertaking (JU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The mental health impact of impaired awareness of hypoglycaemia (IAH) in people with type 2 diabetes (T2D) is not known. We explored this in people with insulin‐treated T2D and type 1 diabetes (T1D).

Methods

Hypo‐METRICS was a 10‐week cross‐sectional observation of hypoglycaemia experience, collecting data on glucose and activity.

Participants

(325 insulin‐treated T2D, 277 T1D) completed questionnaires scoring depression (PHQ‐9), anxiety (GAD‐7), diabetes distress (PAID) and fear of hypoglycaemia (HFS‐II [worry]) at baseline. IAH was defined as a Gold score ≥4. Relationships between IAH and mental health scores were explored using unadjusted and adjusted generalised linear regression analyses. Age, sex, race, diabetes duration, level of education, employment status, continuous glucose monitoring (CGM) use, hypoglycaemia, use of anti‐depressants and use of anti‐anxiety medications were covariates in the adjusted regression.

Results

In unadjusted regression in insulin‐treated T2D, IAH was associated with higher PHQ‐9 (6.4% [1.5%–11.3%]; p = 0.011), GAD‐7 (7.6% [2.1%–13%]; p = 0.006) and HFS‐II (worry) (7.4% [2.8%–12%]; p = 0.002) scores, with no differences in PAID ( p = 0.655). After adjustment, IAH was associated with higher HFS‐II (worry) (5.3% [0.3%–10.6%]; p = 0.048) only. In T1D, IAH was associated with higher PHQ‐9 (6.2% [1.3%–10.8%]; p = 0.012), GAD‐7 (6.1% [0.1%–12.2%]; p = 0.046) and HFS‐II (worry) (6.1% [0.06%–11.5%]; p = 0.029) scores, but not PAID ( p = 0.654), all unadjusted. These relationships remained after adjustment, which also showed higher PAID (8.43% [2.62%–14.24%]; p = 0.005).

Conclusion

Our data demonstrated associations between IAH and a greater mental health burden in both insulin‐treated T2D and T1D. Addressing these mental health challenges should be an important part of the holistic care of people with IAH and insulin‐treated diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoglycemiaDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2InsulinHypoglycemic AgentsMental HealthAwarenessHumansFemaleMaleCross-Sectional StudiesMiddle AgedAnxietyContinuous Glucose MonitoringAdultDepressionBlood GlucoseSurveys and QuestionnairesFear

Stichwörter der Autor:innen

continuous blood glucose monitoringhypoglycaemiaimpaired awareness of hypoglycaemiainsulin‐treated type 2 diabetesmental healthtype 1 diabetes

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • University College Dublin, Dublin, Ireland.
  • Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Department of Computer Sciences, Maynooth University, Maynooth, Ireland.
  • Department of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Department of Medical Psychology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Department of Psychology, University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Aisling McCarthy, Jonah Thomas, Eduardo Avila, Natalie Zaremba, Stephanie A Amiel, François Pouwer, Pratik Choudhary

Förderung

  • Innovative Medicines Initiative 2 Joint Undertaking (JU)

Zitieren

APA

McCarthy, A., Thomas, J., Avila, E., Koutroukas, V., Pieri, B., Zaremba, N., Amiel, S. A., Pouwer, F., Choudhary, P., Divilly, P., & Hypo‐RESOLVE Consortium (2026). Associations between impaired awareness of hypoglycaemia and mental health in insulin‐treated type 2 and type 1 diabetes in the Hypo‐ METRICS study. Diabetic Medicine, 43(3). https://doi.org/10.1111/dme.70194

Vancouver

McCarthy A, Thomas J, Avila E, Koutroukas V, Pieri B, Zaremba N, et al. Associations between impaired awareness of hypoglycaemia and mental health in insulin‐treated type 2 and type 1 diabetes in the Hypo‐ METRICS study. Diabetic Medicine. 2026;43(3). doi:10.1111/dme.70194

BibTeX
@article{McCarthy2026,
  author = {McCarthy, Aisling and Thomas, Jonah and Avila, Eduardo and Koutroukas, Vaios and Pieri, Beatrice and Zaremba, Natalie and Amiel, Stephanie A and Pouwer, François and Choudhary, Pratik and Divilly, Patrick and Hypo‐RESOLVE Consortium, Hypo‐RESOLVE Consortium},
  title = {Associations between impaired awareness of hypoglycaemia and mental health in insulin‐treated type 2 and type 1 diabetes in the Hypo‐ METRICS study},
  journal = {Diabetic Medicine},
  year = {2026},
  volume = {43},
  number = {3},
  doi = {10.1111/dme.70194}
}
Kostenlos starten →